Drug intelligence / Profile preview

Revolution Plus

Development stage
Unknown
Lead developer
Zoetis
Modality
Small Molecules
Administration
Topical
01

Overview

Revolution Plus is a prescription, monthly topical combination antiparasitic medication for cats and kittens. It contains two active ingredients, selamectin (a macrocyclic lactone of the avermectin class) and sarolaner (an isoxazoline). Selamectin works by interfering with chloride channel conductance in nerve and muscle cells of parasites, leading to paralysis and death. Sarolaner blocks GABA- and glutamate-gated chloride channels in insects and acarines, causing increased nerve stimulation that results in parasite death. Revolution Plus provides broad-spectrum protection against fleas (Ctenocephalides felis), four types of ticks (Amblyomma americanum, Amblyomma maculatum, Dermacentor variabilis, Ixodes scapularis), heartworm disease (Dirofilaria immitis), ear mites (Otodectes cynotis), roundworms (Toxocara cati), hookworms (Ancylostoma tubaeforme), as well as preventing flea tapeworm infection by killing fleas before they can transmit Dipylidium caninum. It is approved for use in cats 8 weeks or older weighing at least 2.8 lbs[3][4][6][7][10].

Brand names
Revolution Plus
Other names
selamectin and sarolaner topical solution
02

Targets

GluCl (Glutamate-gated chloride channel)RDL (Insect GABA-gated chloride channel)

Beyond the preview

Go deeper on Revolution Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Revolution Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call